Effectiveness of GLP-1 RAs and SGLT2 inhibitors in preventing T2DM in high-risk patients: an updated systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Clinical Diabetes and Healthcare
Published
2025-12-10
DOI
https://doi.org/10.3389/fcdhc.2025.1694808
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of GLP-1 RAs and SGLT2 inhibitors in preventing T2DM in high-risk patients: an updated systematic review and meta-analysis

George Ε. Zakynthinos, Αlexandra Bargiota, Georgios I. Tsironikos, Vasiliki Tsolaki et al.
1 citations
Frontiers in Clinical Diabetes and Healthcare
Diabetes Treatment and Management
1.29
article

Effectiveness of GLP-1 RAs and SGLT2 inhibitors in preventing T2DM in high-risk patients: an updated systematic review and meta-analysis

George Ε. Zakynthinos, Αlexandra Bargiota, Georgios I. Tsironikos, Vasiliki Tsolaki, Theodoros Mprotsis, Εpameinondas Zakynthinos, Vasiliki Rammou, Despoina Kyprianidou, Thomas Antonogiannis
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in Clinical Diabetes and HealthcareVol. 6
University of Thessaly (GR), University of Ioannina (GR), National and Kapodistrian University of Athens (GR), University Hospital of Larissa (GR), Sotiria General Hospital (GR)
Openalex Percentile: Top 13%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.